How is graft versus host disease diagnosed and monitored in acute myeloid leukemia patients?

How is graft versus host disease diagnosed and monitored in acute myeloid leukemia patients?
Barriers to Stem Cell Transplant in #AML: NC Cohort Insights | Michele Sainvil, MD | #ASH24
TP53-Mutated AML & MDS: Why Clinical Trials Are Your Best Option | Dan Link, MD | #ASH24
Adding Menin Inhibitors in Combination Therapy for AML Patients | Amir Fathi, MD | #ASH24
Promising Early Results from Menin Inhibitors for Treating AML | Harry Erba, MD | #ASH24
BETA - What are the lab abnormalities you will usually see in newly diagnosed AML?